𝔖 Bobbio Scriptorium

✦ LIBER ✦

Comparison of acellular (B type) and whole-cell pertussis-component diphtheria-tetanus-pertussis vaccines as the first booster immunization in 15-to 24-month-old children

✍ Scribed by Sandor Feldman; C. Steve Perry; Michael Andrew; Leslie Jones; John E. Moffitt

Book ID: 117162139
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 417 KB
Volume: 121
Category: Article
ISSN: 1097-6833
DOI: 10.1016/s0022-3476(05)80328-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of an acellular pertussis-com

Comparison of an acellular pertussis-component diphtheria-tetanus-pertussis (DTP) vaccine with a whole-cell pertussis-component DTP vaccine in 17- to 24-month-old children, with measurement of 69-kilodalton outer membrane protein antibody

✍ Dean A. Blumberg; ChrisAnna M. Mink; James D. Cherry; Keith S. Reisinger; Mark M 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 439 KB

Reactogenicity and immunogenicity of red

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccines as a booster in 4–7-year-old children primed with diphtheria–tetanus–whole cell pertussis vaccine before 2 years of age

✍ Ron Dagan; Karim Igbaria; Lolita Piglansky; Francis Van Brusteghem; Vincent Melo 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 302 KB

Effect of priming with diphtheria and te

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children

✍ Audino Podda; Gianni Bona; Gianpaolo Canciani; Anna Maria Casadei Pistilli; Brun 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Reactogenicity and immunogenicity of red

Reactogenicity and immunogenicity of reduced antigen content diphtheria–tetanus–acellular pertussis vaccine (dTpa) administered as a booster to 4–6 year-old children primed with four doses of whole-cell pertussis vaccine

✍ Pensri Kosuwon; Boonyarat Warachit; Yanee Hutagalung; Thitiporn Borkird; Pope Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 179 KB

Antibody persistence against diphtheria,

Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5–6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acellular pertussis vaccine given as a second booster

✍ Eric Mallet; Noëlle Matisse; Nicolas Mathieu; Jacques Langue; Florence Boisnard; 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Post-licensure comparison of the safety

Post-licensure comparison of the safety profile of diphtheria/tetanus/whole cell pertussis/haemophilus influenza type b vaccine and a 5-in-1 diphtheria/tetanus/acellular pertussis/haemophilus influenza type b/polio vaccine in the United Kingdom

✍ Nick Andrews; Julia Stowe; Lesley Wise; Elizabeth Miller 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 485 KB